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Analysis of rhesus macaque leukocytes disclosed the presence of an 18-residue
macrocyclic, tridisulfide antibiotic peptide in granules of neutrophils and mono-
cytes. The peptide, termed rhesus theta defensin-1 (RTD-1), is microbicidal for
bacteria and fungi at low micromolar concentrations. Antibacterial activity of
the cyclic peptide was threefold greater than that of an open-chain analog, and
the cyclic conformation was required for antimicrobial activity in the presence
of 150 millimolar sodium chloride. Biosynthesis of RTD-1 involves the head-
to-tail ligation of two a-defensin–related nonapeptides, requiring the forma-
tion of two new peptide bonds. Thus, host defense cells possess mechanisms
for synthesis and granular packaging of macrocyclic antibiotic peptides that are
components of the phagocyte antimicrobial armamentarium.
Antimicrobial peptides are evolutionarily an-
cient elements of innate immunity (1). Mam-
malian defensins, comprising genetically dis-
tinct a and b subfamilies, are cationic, tridi-
sulfide peptides of 29 to 42 amino acids
length that possess potent broad-spectrum
microbicidal activities in vitro (2). Many de-
fensins appear to be expressed constitutively,
whereas the biosynthesis of others is induced
by mediators of inflammation (3). Neutrophil
a-defensins are packaged in azurophil gran-
ules that are mobilized during phagocytosis
for delivery to phagosomes containing ingest-
ed microbes. In vitro studies demonstrate that
defensins kill microorganisms by permeabi-
lizing one or more target cell membranes (4).
We undertook studies to characterize de-
fensin expression in the leukocytes of rhesus
macaques. In addition to several a-defensins
isolated from monkey neutrophils, we isolat-
ed a tridisulfide-containing antimicrobial
peptide, termed rhesus theta defensin 1
(RTD-1), in which the peptide backbone is
naturally cyclized.
Isolation and characterization of RTD-1.
RTD-1 was isolated from rhesus macaque
leukocytes [.90% polymorphonuclear (PMN)]
by reversed-phase (RP) high-performance liq-
uid chromatography (HPLC) of a whole-cell
extract enriched for a-defensins (Fig. 1) (5).
Chromatographic peaks eluting between 20 and
50 min were purified to homogeneity and
screened for antibacterial activity against Esch-
erichia coli ML35 and Staphylococcus aureus
502a (6), and microbicidal peptides were char-
acterized by amino acid analysis and automated
Edman degradation (7). Seven of the eight
purified antimicrobial peptides were a-de-
fensins that were similar in sequence and activ-
ity to orthologous human peptides (8). RTD-1
(arrow in Fig. 1A) was relatively abundant and
possessed the greatest antibacterial activity of
any of the peptides isolated. The yield of
RTD-1 was ;100 mg per 109 neutrophils.
Amino acid analysis of RTD-1 revealed that
it was composed of 18 amino acids: 1 Thr, 1
Val, 1 Leu, 1 Phe, 1 Ile, 2 Gly, 5 Arg, and 6 Cys.
MALDI-TOF MS analysis (9) of the native
(2082.0) and S-pyridylethylated (10) (2720.3)
peptides demonstrated that the six cysteines
exist as three intramolecular disulfides. Because
the peptide’s apparent NH2-terminus was
blocked, the primary structure of RTD-1 was
determined by sequencing overlapping frag-
ments produced by methanolic-HCl treatment
(11) and digestion with chymotrypsin and tryp-
sin (12) (Fig. 2A). These analyses revealed that
the RTD-1 backbone is cyclized through pep-
tide bonds (Fig. 2B). The cyclic conformation
accounts for the 18 atomic mass unit difference
(equal to one water molecule) between the mea-
sured mass (2082.0; 2081.6 calculated) of
RTD-1 and that of a linear tridisulfide peptide
(2099.6 calculated) of the same composition.
The disulfide structure of RTD-1 was deter-
mined by characterizing protease digestion
fragments produced by sequential incubation of
native peptide with trypsin and thermolysin
(13). Following trypsin digestion, a major prod-
uct was purified by HPLC and its mass was
determined to be 1998.1. Comparison of the
mass and amino acid analysis of this peptide
revealed that it was produced by cleavage at the
COOH side of all five arginine residues, thus
generating a 17-residue oligopeptide (or 17-
mer) composed of four peptides linked by three
disulfides (calculated mass 5 1997.5; Fig. 2C).
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Fig. 1. Purification of RTD-1. (A) RP-
HPLC of peripheral blood leukocyte
extracts. An a-defensin-enriched ex-
tract of 6 3 106 leukocytes (91%
PMNs) (8) was fractionated by RP-
HPLC on a 0.46 3 25 cm C-18 col-
umn equilibrated in 0.1% aqueous
TFA and developed with a linear
acetonitrile gradient (dotted line).
RTD-1 eluted in the arrow-marked
peak. (B) Analytical RP-HPLC of pu-
rified RTD-1. The purity of RTD-1
was assessed by RP-HPLC of RTD-1
obtained from the peak (arrow) in
(A) on an analytical C-18 column
equilibrated in aqueous 0.13% HFBA
and developed with a linear (20 to
60%) acetonitrile gradient in 20
min. (C) Acid-urea PAGE. Samples of
30% acetic acid granulocyte extract
(2 3 106 cell equivalents; lane 1),
the subsequent methanol:water ex-
tract (1 3 107 cell equivalents; lane
2), and 0.4 mg of RTD-1 were re-
solved on a 12.5% acid-urea poly-
acrylamide gel and stained with for-
malin-Coomassie blue.
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To distinguish between the eight possible disul-
fide pairings in the 17-mer, the oligopeptide
was digested with thermolysin and the resulting
fragments were analyzed by MALDI-TOF MS
(9). The m/z values of the thermolysin frag-
ments were consistent with only one cystine
motif (Fig. 2C), revealing that the peptide ring
is stabilized by three disulfides in a picket
fence–like array that crosslinks two hypotheti-
cal b-strands connected by turns at both ends
(Fig. 2, D and E). Schematically, RTD-1 resem-
bles the Greek letter theta (Fig. 2D), hence the
selection of u-defensin to describe this molec-
ular motif. The peptide is highly cationic, pos-
sessing a net charge of 15 at pH 7 (calculated
pI . 12), and the dense cystine motif is distinct
from that determined for a- or b-defensins
(14).
The structure and activities of RTD-1
were confirmed by the preparation and char-
acterization of synthetic RTD-1. The purified
synthetic product was identical to natural
RTD-1 as determined by RP-HPLC, acid-
urea polyacrylamide gel electrophoresis
(PAGE), circular dichroism spectroscopy, di-
sulfide motif, and quantitative microbicidal
activity [supplemental figures 1 and 2 (15)].
Together these data confirm the structure and
biological activity of native RTD-1.
Searches for amino acid sequence similarity
to RTD-1 were carried out using all 18 possible
linearized peptides as query sequences (16).
Taking into consideration the cysteine spacing
and disulfide connectivities of RTD-1, the most
similar polypeptide sequence identified was
that of protegrin-3 (PG-3), an antimicrobial
peptide from pig neutrophils (17). Protegrins
are 17- to 18–amino acid, bis-disulfide–con-
taining peptides that are members of the cathe-
licidin family of antimicrobial peptides (18).
Like protegrins, RTD-1 is predicted to be pre-
dominantly composed of two disulfide-stabi-
lized b-strands connected by turns. A model of
RTD-1, derived from molecular dynamics sim-
ulations (Fig. 2E) (19), is remarkably similar to
the solution structure of protegrin-1 (PG-1), an
isoform of PG-3. Despite this similarity, clon-
ing experiments revealed that RTD-1 is not a
rhesus cathelicidin.
The occurrence of RTD-1 in primate phago-
cytes discloses a structural motif in animals
resembling a group of macrocyclic peptides
previously characterized in plants. Like RTD-1,
cyclic peptides isolated from plants of the Ru-
biaceae family molecules possess three in-
tramolecular disulfides (20). Two of these pep-
tides are reported to be antiviral against HIV-1
(21). The plant peptides differ from RTD-1 in
their size (29 to 31 versus 18 amino acids,
respectively) and they contain a cystine motif
that is characterized by “overlapping” disul-
fides that produce a cystine knot (22). Thus far,
the genes encoding these plant peptides have
not been reported, nor have mechanisms been
proposed for the formation of the cyclic back-
bone. The only other macrocyclic peptides that
we are aware of lack disulfides. One, AS-48, is
a plasmid-encoded peptide expressed by En-
terococcus faecalis (23); the second is J25, a
microcin from E. coli (24).
Cloning of RTD-1 precursors. To eluci-
date the RTD-1 biosynthetic pathway, we
sought to characterize the peptide precursor by
analysis of one or more of the corresponding
cDNAs from rhesus macaque bone marrow
mRNA. Because the NH2-terminus of RTD-1
could not be predicted from its cyclic sequence,
we conducted 39 RACE (rapid amplification of
cDNA ends) experiments using degenerate oli-
gonucleotide primers corresponding to six to
seven amino acid segments of the peptide se-
quence (25). These amplifications consistently
yielded two sequences that separately corre-
sponded to different portions of RTD-1: R8-R9-
G10-V11-C12-[Q-L-L-stop] and T17-R18-G1-F2-
C3-[R-L-L-stop] (Fig. 2D) (25). The 39 RACE
products were then used to probe a rhesus
macaque bone marrow cDNA library (26). Fif-
teen positive clones were isolated and se-
quenced, revealing two highly similar cDNAs
(92% identity) termed RTD1a and RTD1b
(Genbank accession numbers AF191100 and
AF191101, respectively). Surprisingly, none of
the clones analyzed contained a sequence that
coded for all 18 amino acids in RTD-1.
RTD1a and RTD1b each encode 76–ami-
no acid pre-propeptides containing a 20-res-
idue signal peptide and a 44–amino acid
prosegment, which are identical in size and
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Fig. 2. Peptide backbone
structure of RTD-1. (A)
The amino acid sequence
of the peptide chain was
determined by Edman se-
quencing or MALDI-TOF
MS, or both, of fragments
produced by methanolic-
HCl treatment or diges-
tion with chymotrypsin
(CT) and trypsin (T). Di-
sulfides were reduced with
dithiothreitol and alky-
lated with 4-vinyl pyri-
dine before digestion so
that cysteines were ana-
lyzed as S-pyridylethyl
cysteine. Residues in pa-
rentheses were assigned
based on MALDI-TOF MS
data. Calculated MALDI-
TOF MS values are in pa-
rentheses. (B) Amino acid
sequence of the RTD-1
peptide backbone. (C) Di-
sulfide analysis of RTD-1.
A tridisulfide-containing
17-residue oligopeptide
generated by trypsin di-
gestion was purified by
RP-HPLC and digested
further with thermolysin
(13). MS analyses (calcu-
lated values in parenthe-
ses) of the digest dis-
closed thermolytic cleav-
age at Cys-14/Ile-15 and
at Cys-5/Leu-6 (arrows), producing four major thermolytic fragments (Th-1 to Th-4). The masses
of all fragments from several digests were uniquely consistent with the disulfide assignments
shown. (D) Schematic of the covalent structure of RTD-1. The highlighted amino acids correspond
to the two 39 RACE products obtained (25), and the color scheme indicates the precursors (Fig. 3,
A and C) from which they are derived. (E) A theoretical model of RTD-1 obtained by molecular
dynamics and energy minimization in water is shown (19).
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similar in sequence to homologous regions of
a-defensin precursors (Fig. 3A) (27). Align-
ment (16) of the RTD1a- and RTD1b-de-
duced precursor sequences with that of HNP-
4, the most similar a-defensin, disclosed sub-
stantial similarities at the amino acid level
(Fig. 3A). However, the covalent structures
of mature RTD-1 and HNP-4 (30 amino ac-
ids) are markedly dissimilar (28). Further-
more, compared to a-defensins, RTD-1 pre-
cursors have truncated COOH-terminal seg-
ments, encoding only 12 residues after the pu-
tative junction between the prosegment and a
COOH-terminal dodecapeptide (Fig. 3A).
Genomic clones RTD1.1 and RTD1.2,
corresponding to the RTD1a and RTD1b cD-
NAs, respectively, were isolated from a rhe-
sus macaque genomic library (29), confirm-
ing that the cDNAs derive from distinct tran-
scriptional units. RTD1.1 and RTD1.2 are
93% identical, and the three-exon, two-intron
gene structure and organization that they
share are very similar to those of the myeloid
a-defensin genes characterized previously in
humans, rabbits, and guinea pigs (Fig. 3B)
(30). The close relationship between the
RTD-1 and a-defensin genes is also shown
by their 88% nucleotide sequence identity
with a human a-defensin–related pseudogene
(accession U10267). Interestingly, one of the
stop codons in this pseudogene corresponds
exactly to the position of the stop codons that
truncate RTD-1 coding sequences (Fig. 3A).
Comparison of the RTD-1 covalent struc-
ture with that of the deduced RTD1a and
RTD1b translation products revealed that the
cyclic peptide is composed of two nine-resi-
due peptides that are derived separately from
the RTD1a and RTD1b precursors. RTD-1
peptide residues 13 to 18 and 1 to 3 corre-
spond to amino acids 65 to 73 from RTD1a,
and RTD-1 residues 4 to 12 correspond to
RTD1b amino acids 65 to 73 (Fig. 3, A and
C). The transformation of the two linear pre-
cursors into cyclic RTD-1 requires that two
head-to-tail ligation reactions join the constit-
uent nonapeptides by posttranslational reac-
tions not previously recognized (Fig. 3C).
Expression of RTD-1 in myelopoietic
elements. The anatomic distribution of RTD-1
gene expression in rhesus macaque tissues
was determined by Northern blotting using a
probe specific for RTD-1 mRNAs (31). Of
the 18 organs analyzed, only bone marrow
was positive for RTD-1 mRNA (Fig. 4A).
The leukocytic lineages in which RTD-1 is
expressed were identified by immunohisto-
chemical staining with an anti–RTD-1 anti-
body (32). Dot blot analysis demonstrated
that anti–RTD-1 antiserum reacted with nat-
ural and synthetic RTD-1 and the oxidized
acyclic version of RTD-1, but did not recog-
nize any of the previously characterized
a-defensins (HNP-1 through HNP-4) ex-
pressed by human leukocytes nor any of the
rhesus leukocyte a-defensins. Immunostain-
ing of buffy coat leukocytes demonstrated
strong, punctate staining in neutrophil cyto-
plasm, similar to the immunolocalization of
neutrophil a-defensins, which are stored in
azurophil granules (Fig. 4, B and C). Al-
though less reactive than neutrophils, mono-
cytes were also immunopositive, but lympho-
cytes and eosinophils were negative. Thus,
RTD-1 is expressed in the two major phago-
cytic cells of the blood.
RTD-1 gene expression and peptide accu-
mulation begin early during granulocyte myelo-
poiesis. Staining of bone marrow cells with
anti–RTD-1 antibody demonstrated immunore-
activity in the cytoplasm of immature myeloid
elements (promyelocytes, myelocytes) and in
mature neutrophils and monocytes (Fig. 4D).
This pattern of expression during myeloid dif-
ferentiation and the punctate pattern of immu-
nostaining are consistent with the packaging of
RTD-1 in azurophil granules.
Microbicidal activity. The in vitro anti-
microbial properties of RTD-1 were evaluat-
ed in microbicidal assays against a panel of
bacterial and fungal test organisms. The
broad spectrum of RTD-1 antimicrobial ac-
tivity was demonstrated in microbicidal as-
says against Gram-positive bacteria (S. au-
reus, Listeria monocytogenes), Gram-nega-
tive bacteria (E. coli ML 35, Salmonella ty-
phimurium), and fungi (Candida albicans
and Cryptococcus neoformans). The viability
of each organism was reduced by more than
99% after 2-hour incubations with 2 to 4
mg/ml RTD-1, and higher peptide concentra-
tions (up to 20 mg/ml) effected killing to
levels below the detection limit of the assay
(Fig. 5, A through C).
The mechanistic significance of the RTD-1
A
B
C
Fig. 3. RTD-1 precursors and genes. (A) Deduced RTD1a, RTD 1b, human defensin-like pseudogene
(GenBank accession number U10267), and HNP-4 precursor sequences are aligned with in-frame
amino acid translations through the mature defensin coding region. Constituent RTD-1 sequences
derived from RTD1a and RTD1b (3-Cys) are color coded as in Fig. 2D and 3C; white background
corresponds to non-translated sequences. Dot characters denote amino acid identity with the
RTD1a deduced precursor. The Ù symbols denote positions of polypeptide chain truncation by
termination codons. (B) Genomic organization of RTD1.1 (accession number AF191102) and RTD1.2
(accession number AF191103). Exons and introns are shown to scale. The bottom line shows the
mRNA-prepropeptide relationship. (C) Posttranslational processing of RTD-1 precursors. Small
arrows denote the boundaries within the RTD1a and RTD1b propeptides that separate each
nonapeptide, present in mature RTD-1, from flanking sequences absent in the cyclic structure. The
color scheme is consistent with that shown in Figs. 2D and 3A.
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cyclization was investigated by comparing the
antibacterial activities of the cyclic peptide to
that of the tridisulfide-containing acyclic analog
from which it was produced [supplemental fig-
ure 1 (15)]. The peptides were tested for activity
against S. aureus and E. coli in an agar diffu-
sion antimicrobial assay (6). RTD-1 was three
times as active as the acyclic analog against
both organisms, indicating that cyclization con-
fers a substantial increase in antimicrobial po-
tency (Fig. 5, D and E).
Previous studies have demonstrated that
a- and b-defensin–mediated microbicidal ac-
tivity is antagonized by increasing the ionic
strength of the incubation medium (33). In
this context, it has been proposed that salt
sensitivity of airway b-defensins underlies
the susceptibility of cystic fibrosis patients to
pulmonary infections (34). Therefore, the ef-
fect of ionic strength on natural and synthetic
RTD-1 staphylocidal activity was deter-
mined. Sodium chloride concentrations as
high as 150 mM had little effect on the
staphylocidal activity of natural or synthetic
RTD-1 (Fig. 5F), but the acyclic form of
RTD-1 was inhibited nearly completely by
125 mM NaCl. These data demonstrate that
the cyclized conformation confers salt-insen-
sitivity to RTD-1. We speculate that under
conditions of low (Fig. 5, D and E) and high
(Fig. 5F) ionic strength, the cyclic conformer
more efficiently binds to and inserts into the
target cell envelope than does the acyclic
peptide, which possesses additional charge at
both termini.
The broad spectrum of RTD-1 antimicro-
bial activity and its expression in phagocytes
raises questions about the evolutionary forces
that might have selected for the production of
Fig. 4. RTD-1 mRNA and peptide expression. (A) Multiple tissue Northern blot probed
with theta defensin-specific PCR product. Lower panel shows ethidium bromide
staining of the gel demonstrating RNA integrity and relative loading. (B) Immunostain-
ing of peripheral blood buffy coat cells with anti–RTD-1 antibody (32) demonstrates
strong staining of neutrophils, lighter staining of monocytes (hollow arrow), and no
staining of lymphocytes and eosinophils (solid arrow). (C) Negative control incubation
with buffy coat incubated with RTD-1–preabsorbed antiserum. (D) Bone marrow cells
were stained with anti–RTD-1 antiserum as in (B). Two representative fields demon-
strate strong staining in the cytoplasm of neutrophilic precursors (promyelocyte, Pm;
myelocyte, Mc) and segmented neutrophils (hollow arrows). Monocytes (Mo) stain less
strongly, and eosinophils (E) are negative.
Fig. 5. Microbicidal activity of RTD-1. (A through C) Each test organism was incubated with RTD-1
at varied concentrations in 10 mM PIPES buffer containing 5 mM glucose for 2 hours at 37°C (36).
The limit of detection (1 colony per plate) was equal to 1 3 103 colony forming units per milliliter
in the incubation mixture. (D through E) Microbicidal activity of RTD-1 and acyclic RTD-1.
Antibacterial activity against S. aureus 502a and E. coli ML35 was assessed in an agar diffusion
assay (6). Zones of clearing were measured after 18 hours incubation. (F). Salt insensitivity of
RTD-1. Killing of S. aureus 502a was assessed after 2 hours incubation with 10 mg/ml of natural
RTD-1, synthetic RTD-1, or synthetic acyclic RTD-1 in 10 mM PIPES buffer, pH 7.4 containing 5 mM
glucose. Incubations mixtures were supplemented with increasing concentrations of NaCl. Percent
killing was determined by colony counting.
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a cyclic antimicrobial molecule. We specu-
late that the compact structure of RTD-1
confers resistance to proteases that are abun-
dant in inflammatory exudates, and the lack
of NH2- and COOH-termini eliminates its
susceptibility to exopeptidases. In addition,
the cyclic conformation confers increased mi-
crobicidal activity compared to an acyclic,
tridisulfide-containing analog (Fig. 5, D and
E), as is required for antibacterial activity in
150 mM NaCl (Fig. 5F).
The cyclic structure of RTD-1 demon-
strates that primate cells possess a posttrans-
lational processing pathway capable of head-
to-tail peptide chain ligation. The processing
pathway that produces the mature RTD-1
from two precursor propeptides requires the
proteolytic removal of the prosegments and
the COOH-terminal tripeptides from each
propeptide (Fig. 3C). While it is possible that
disulfide rearrangement may occur in this
process, the formation of the one interchain
and two intrachain disulfides (Fig. 3C) could
position the two hairpin halves of RTD-1 so
that the NH2- and COOH-termini are in prox-
imity for subsequent ligation. It seems likely
that the posttranslational pathway employed
in the synthesis of RTD-1 is used for the
cyclization of other polypeptide precursors.
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